Evidence map›Paper›PMID 22424883›Full record

ArticleThe Journal of allergy and clinical immunology2012

Genome-wide association study of lung function decline in adults with and without asthma.

Medea Imboden, Emmanuelle Bouzigon, Ivan Curjuric, Adaikalavan Ramasamy, Ashish Kumar, Dana B Hancock, Jemma B Wilk, Judith M Vonk, Gian A Thun, Valerie Siroux and 24 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of allergy and clinical immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 4 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Swiss Cohort & Biobank - The White Paper.Public health reviews · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 9 countries.

Medea ImbodenSwiss Tropical and Public Health Institute, Basel, Switzerland.
Emmanuelle Bouzigon
Ivan Curjuric
Adaikalavan Ramasamy
Ashish Kumar
Dana B Hancock
Jemma B Wilk
Judith M Vonk
Gian A Thun
Valerie Siroux
Rachel Nadif
Florent Monier
Juan R Gonzalez
Matthias Wjst
Joachim Heinrich
Laura R Loehr
Nora Franceschini
Kari E North
Janine Altmüller
Gerard H Koppelman
Stefano Guerra
Florian Kronenberg
Mark Lathrop
Miriam F Moffatt
George T O'Connor
David P Strachan
Dirkje S Postma
Stephanie J London
Christian Schindler
Manolis Kogevinas
Francine Kauffmann
Debbie L Jarvis
Florence Demenais
Nicole M Probst-Hensch
Swiss Tropical and Public Health Institute · CHInserm · FRUniversity of North Carolina at Chapel Hill · USHelmholtz Zentrum München · DENational Institute of Environmental Health Sciences · USUniversity Medical Center Groningen · NLBoston University · USCenter for Research in Environmental Epidemiology · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDélégation Paris 7 · FRFondation Jean Dausset-CEPH · FRFramingham Heart Study · USImperial College London · GBInnsbruck Medical University · ATNational School of Public Health · GRSt George's, University of London · GBUniversité Paris Cité · FRUniversity of Basel · CHUniversity of Cologne · DEUniversity of Groningen · NL

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
Translational Research Support CoreP30ES007048 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROB S MCCONNELL · 1996 to 2026
$46.4M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
Genetics and Environment in Adult Respiratory, Allergic and Cardiac diseaseZIAES043012 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI LONDON, STEPHANIE · 2009 to 2025
$6.4M
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and BloodR01HL087641 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2006 to 2008
$3.7M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
Basal Ganglia and 5-HT in Ritualistic Social DisplaysR01MH062633 · NIMH · UNIVERSITY OF FLORIDA · PI BAXTER, LEWIS R · 2001 to 2005
$1.4M
Genetic /Environment Factors In Nonmalignant Resp DisZ01ES043012 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI LONDON, STEPHANIE JOAN · 1999 to 2008
$340k
COMMUNITY BASED STUDY ON OCCUPATIONAL ASTHMA, ECRHS-OAR01HL062633 · NHLBI · MUNICIPAL INSTITUTE OF MEDICAL RESEARCH · PI KOGEVINAS, MANOLIS · 1999 to 2001
$180k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
Department of HealthIntramural NIH HHS Z01 ES043012Medical Research Council G0000934Medical Research Council G0901214Medical Research Council G1000758Medical Research Council G1001799NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NHGRI NIH HHS U01 HG004402NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01HL59367NHLBI NIH HHS R01 HL62633-01NIDDK NIH HHS U01 DK062418NIEHS NIH HHS P30 ES007048NIMH NIH HHS R01 MH062633Wellcome Trust 068545/Z/02Wellcome Trust 076113/B/04/ZWellcome Trust 097117Wellcome Trust WT084703MA
6 · The paper itself

Abstract

backgroundGenome-wide association studies have identified determinants of chronic obstructive pulmonary disease, asthma, and lung function level; however, none have addressed decline in lung function.

objectiveWe conducted the first genome-wide association study on the age-related decrease in FEV(1) and its ratio to forced vital capacity (FVC) stratified a priori by asthma status.

methodsDiscovery cohorts included adults of European ancestry (1,441 asthmatic and 2,677 nonasthmatic participants: the Epidemiological Study on the Genetics and Environment of Asthma, the Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults, and the European Community Respiratory Health Survey). The associations of FEV(1) and FEV(1)/FVC ratio decrease with 2.5 million single nucleotide polymorphisms (SNPs) were estimated. Thirty loci were followed up by in silico replication (1,160 asthmatic and 10,858 nonasthmatic participants: Atherosclerosis Risk in Communities, the Framingham Heart Study, the British 1958 Birth Cohort, and the Dutch Asthma Study).

resultsMain signals identified differed between asthmatic and nonasthmatic participants. None of the SNPs reached genome-wide significance. The association between the height-related gene DLEU7 and FEV(1) decrease suggested for nonasthmatic participants in the discovery phase was replicated (discovery, P = 4.8 × 10(-6); replication, P = .03), and additional sensitivity analyses point to a relation to growth. The top ranking signal, TUSC3, which is associated with FEV(1)/FVC ratio decrease in asthmatic participants (P = 5.3 × 10(-8)), did not replicate. SNPs previously associated with cross-sectional lung function were not prominently associated with decline.

conclusionsGenetic heterogeneity of lung function might be extensive. Our results suggest that genetic determinants of longitudinal and cross-sectional lung function differ and vary by asthma status.

Indexed as

Genome-Wide Association StudyAdultAsthmaChromosomes, Human, Pair 13EuropeFemaleFollow-Up StudiesForced Expiratory VolumeHumansLungMaleMembrane ProteinsMiddle AgedNeoplasm ProteinsPolymorphism, Single NucleotideTumor Suppressor ProteinsDLEU7 protein, humanMembrane ProteinsNeoplasm ProteinsTumor Suppressor ProteinsTUSC3 protein, human

Identifiers

PMID22424883
PMCPMC3340499
OpenAlexW2127818071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.